| [1] PubMed ID: | 38767702 |
| Disease Name: | Stomach Neoplasms |
| Tissue: | serum |
| Dysfunction Pattern: | Up-Regulation |
| Validated Method: | RT-PCR//Sequencing |
| Description: | In this research, we screened a differentially expressed molecule tsRNA-Gly-i-0003 from the tsRFun database, called it tRF-17-18VBY9M according to MINT base v2.0, And verified that its expression level was consistent in gastric cancer tissues and serum, which were both significantly up-regulated, and thus hypothesized whether serum tRF-17- 18VBY9M could function as a new biomarker for GC diagnosis and monitoring. |
| Comparision: | Cancer VS Normal |
| Mechanism: | The Chi-square test demonstrated that high-expressed tRF-17-18VBY9M was closely associated with the T stage, tumor node metastasis stage (TNM), lymph node metastasis, and neurological/vascular invasion. ROC curve analysis revealed that the diagnostic value of tRF-17-18VBY9M in GC was superior to carcinoembryonic antigen (CEA), carbohydrate antigen 199 (CA199), and carbohydrate antigen 724 (CA724). |
|